Stonebridge Capital Management’s Medtronic MDT Stock Holding History

Stonebridge Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,175	Closed	-$1.57M	–	171
2015 Q1	$1.57M	Hold	20,175	–	–	0.64%	39
2014 Q4	$1.46M	Hold	20,175	–	–	0.56%	43
2014 Q3	$1.25M	Sell	20,175 -25	-0.1%	-$1.59K	0.48%	47
2014 Q2	$1.29M	Sell	20,200 -54	-0.3%	-$3.28K	0.49%	45
2014 Q1	$1.25M	Sell	20,254 -571	-3%	-$33.3K	0.52%	40
2013 Q4	$1.2M	Sell	20,825 -350	-2%	-$19.8K	0.48%	44
2013 Q3	$1.13M	Sell	21,175 -17,300	-45%	-$931K	0.51%	43
2013 Q2	$1.98M	Buy	+38,475	New	+$1.9M	0.92%	28

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Stonebridge Capital Management's MDT Position: Q2 2015 in Review

Stonebridge Capital Management sold out of Medtronic (MDT) in Q2 2015, closing a stake of 20,175 shares — an estimated $1.57M sold.

Stonebridge Capital Management first reported a position in MDT in Q2 2013 and held it in 8 quarters. The position peaked at $1.98M in Q2 2013. 1,258 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

Stonebridge Capital Management reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
Stonebridge Capital Management sold 20,175 Medtronic shares in Q2 2015, an estimated $1.57M.
Stonebridge Capital Management first reported a position in Medtronic in Q2 2013 and held it in 8 quarters.
Stonebridge Capital Management's Medtronic position peaked at $1.98M in Q2 2013.
1,258 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Stonebridge Capital Management's 13F filing for Q2 2015, filed 16 Jul 2015.